Joel M Van Gelder

Title: The Innovations of Joel M Van Gelder

Introduction

Joel M Van Gelder is an accomplished inventor based in Jerusalem, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the modulation of heparanase activity. His innovative work has the potential to impact the treatment of various diseases and disorders associated with heparanase.

Latest Patents

Joel M Van Gelder holds a patent for "Rigidified compounds for modulating heparanase activity." This patent discloses novel rigidified compounds that feature a rhodanine-like residue and at least one aryl or heteroaryl residue linked to the rhodanine-like residue. The core structure of these compounds is characterized by having one or zero free-to-rotate bonds. Additionally, the patent outlines pharmaceutical compositions containing these rigidified compounds and their uses in modulating the activity of heparanase, as well as in treating heparin-binding proteins-associated diseases and disorders.

Career Highlights

Throughout his career, Joel has been associated with Insight Biopharmaceuticals Ltd., where he has furthered his research and development efforts. His work has been instrumental in advancing the understanding of heparanase and its implications in medical treatments.

Collaborations

Joel M Van Gelder has collaborated with notable colleagues, including Joseph Y Klein and Yochai Basel. These collaborations have contributed to the advancement of research in the pharmaceutical field.

Conclusion

Joel M Van Gelder's innovative contributions to the pharmaceutical industry, particularly through his patent on rigidified compounds, highlight his role as a significant inventor. His work continues to pave the way for advancements in the treatment of heparanase-associated diseases.